BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1736721)

  • 1. Pentapeptide activity.
    Hamburger RN
    Ann Allergy; 1992 Jan; 68(1):68. PubMed ID: 1736721
    [No Abstract]   [Full Text] [Related]  

  • 2. A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111].
    Fenton AJ; Kemp BE; Hammonds RG; Mitchelhill K; Moseley JM; Martin TJ; Nicholson GC
    Endocrinology; 1991 Dec; 129(6):3424-6. PubMed ID: 1954916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of C-terminal fragments of tachykinins.
    Siemion IZ; Kubik A; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):201-3. PubMed ID: 7487353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of igercine--the C-terminal nonapeptide from human immunoglobulin E].
    Chipens GI; Antsans IuE; Biseniece DA; Zarin'sh PP; Osis LP
    Bioorg Khim; 1985 May; 11(5):590-7. PubMed ID: 3840023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human kappa-casein.
    Kohmura M; Nio N; Ariyoshi Y
    Agric Biol Chem; 1990 Mar; 54(3):835-6. PubMed ID: 1368540
    [No Abstract]   [Full Text] [Related]  

  • 6. The 163-171 peptide of human IL-1 beta.
    Boraschi D; Ghiara P; Villa L; Antoni G; Tagliabue A
    Prog Clin Biol Res; 1990; 349():365-74. PubMed ID: 2144645
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of beta-agonists with corresponding beta 2- and beta 1-adrenergic pentapeptide sequences.
    Schmidt WF; Waters RM; Mitchell AD; Warthen JD; Honigberg IL; Van Halbeek H
    Int J Pept Protein Res; 1993 May; 41(5):467-75. PubMed ID: 8100557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of various beta-caseins.
    Kohmura M; Nio N; Ariyoshi Y
    Agric Biol Chem; 1990 Apr; 54(4):1101-2. PubMed ID: 1368548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alternatives to classical immunotherapy and future possibilities].
    Casillas Miranda R; Boudet RV; Vanella LM
    Rev Alerg Mex (1987); 1990; 37(4):133-5. PubMed ID: 2089604
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of prolyl endopeptidase by synthetic peptide fragments of human beta-casein.
    Asano M; Nio N; Ariyoshi Y
    Agric Biol Chem; 1991 Mar; 55(3):825-8. PubMed ID: 1368631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic activity of angiotensin II and its fragments Val-Tyr-Ile-NH2 and Val-Tyr-Ile-His-NH2.
    Własienko J; Braszko JJ; Koziołkiewicz W; Janecka A; Wiśniewski K
    Biomed Biochim Acta; 1989; 48(9):707-13. PubMed ID: 2619739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxic activity of peptides containing basic amino acids residues.
    Chillemi F; Francescato P; Bossa R; Fraccari A; Galatulas I
    Anticancer Res; 1996; 16(2):715-6. PubMed ID: 8687118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active fragments and analogs of the plant growth factor, phytosulfokine: structure-activity relationships.
    Matsubayashi Y; Hanai H; Hara O; Sakagami Y
    Biochem Biophys Res Commun; 1996 Aug; 225(1):209-14. PubMed ID: 8769119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conformational features of a pentapeptide as an element of the active center of human immunoglobulin E].
    Godzhaev NM; Agaeva GA
    Biofizika; 2000; 45(4):581-5. PubMed ID: 11040963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 inhibition by a peptide.
    Jiang S; Lin K; Strick N; Neurath AR
    Nature; 1993 Sep; 365(6442):113. PubMed ID: 8371754
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of lipoxygenase inhibitory peptides from beta-casein by using SPOT synthesis.
    Schurink M; van Berkel WJ; Wichers HJ; Boeriu CG
    Chembiochem; 2006 May; 7(5):743-7. PubMed ID: 16628755
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the coagulating and aggregating activity of alpha-thrombin by a synthetic analog of the thymosin fragment alpha 1(24-28)].
    Strukova SM; Dugina TN; Samal' AB; Smirnova MP; Pinelis VG; Volkova TD
    Biull Eksp Biol Med; 1995 Jul; 120(7):26-9. PubMed ID: 8527773
    [No Abstract]   [Full Text] [Related]  

  • 18. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion.
    Wild C; Greenwell T; Matthews T
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1051-3. PubMed ID: 8312047
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a peptide in enzymatic hydrolyzate of cheese that inhibits ovalbumin permeation in Caco-2 cells.
    Tanabe S; Isobe N; Miyauchi E; Kobayashi S; Suzuki M; Oda M
    J Agric Food Chem; 2006 Sep; 54(18):6904-8. PubMed ID: 16939356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.